Scientific Advisory Board
![Vincent Ling](/curam/about-us/advisory-boards/scientific-advisory-boarda/Vincent-Ling-BW-amended.png)
Vincent Ling
Dr. Ling currently serves as Senior Director within Search and Evaluation, Business Development at Takeda, after directorship roles in external innovation and pharmaceutical sciences.
For over 30 years, Dr. Ling led successful research and business innovation groups in diverse biotechnology fields, including cell devices, protein engineering, biosimilars, stem cell differentiation, checkpoint inhibitors and molecular evolution of antibody scaffolds. He has held leadership positions in large, midsized and start-up environments, creating practical biotherapeutics.
His current interests lie in novel drug delivery technologies, which includes drug particles, energy guidance and biomaterial scaffolds. Dr. Ling currently serves as Senior Director within Search and Evaluation, Business Development at Takeda, after directorship roles in external innovation and pharmaceutical sciences.
Prior to Takeda, Dr. Ling was Head of Biological Sciences developing cell therapies for wet AMD at Neurotech. He has held positions including Vice President at Dragonfly Sciences, managing all scientific operations and marketing functions, Director of Molecular Genetics at Adnexus (Compound Therapeutics), and other scientific roles in Discovery Research at Genetics Institute and Wyeth Pharmaceuticals.
Dr. Ling earned a BA in Molecular Biology at University of California, Berkeley, followed by MS and Ph.D at University of Illinois, and postdoctoral training at the Harvard Biological Laboratories.